AC-262,536
AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator (SARM). Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a Ki of 5nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the anabolic action of testosterone, but only around 27% of its potency as an androgen
Technical Data for AC-262,536
| M. Wt | 278.36 |
| Formula | C18H18N2O |
| Storage | Store at RT |
| Purity | ≥99% (HPLC) |
| CAS Number | 870888-46-3 |
| EINECS | 870888-460-3 |
| Appearance | Powder form |
| Smiles | O[C@@H]1C[C@H]2N(C3=CC=C(C#N)C4=C3C=CC=C4)[C@@H](C1)CC2 |
Chemical name 4-[(3-endo)-
Benefit of AC-262,536
- Build Muscle
- Prevent prostate cancer
- Prevent alzheiner’s disease
Side effect of AC-262,356
It provides many of the same powerful benefits of anabolic steroids without the notable side effects Currently.
WARNING This product is not for human or veterinary use.